HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,354 | +12.5% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15,428 | -5.8% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $16,371 | -4.1% | 150 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $17,070 | -10.2% | 150 | -50.0% | 0.00% | 0.0% |
| Q3 2022 | $19,000 | -20.8% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $32,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -3.0% | 300 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $33,000 | +266.7% | 300 | +200.0% | 0.00% | +200.0% |
| Q2 2021 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | +28.6% | 100 | -1.0% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | -12.5% | 101 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |